Myriad Genetics | 8-K: Myriad Genetics Reports First Quarter 2023 Financial Results; Achieves 10% Revenue Growth Year-Over-Year, the Second Consecutive Quarter of Double-Digit Year-Over-Year Revenue Growth; Raises Mid-Point of 2023 Revenue Guidance Range

萬基遺傳 | 8-K：Myriad Genetics公佈2023年第一季度財務業績；收入同比增長10％，這是連續第二個季度實現兩位數的同比收入增長；提高了2023年收入指導區間的中點